Back to Vanguard Group Inc. Vanguard Group Inc.

VKTX

6 quarters

Position history for Vanguard Group Inc.Vanguard Group Inc.'s holdings in Viking Therapeutics, Inc.

As of its last 13F, for Q4 2025, Vanguard Group held 9,984,487 shares of VKTX (Viking Therapeutics), worth $351.3M. It reduced the position by 14,620 shares (-0.2%) from Q3 2025. Vanguard Group held VKTX from Q3 2024 to Q4 2025, across 6 quarterly 13F filings.

Current Value

$351.3M

Current Shares

10M

Total Value Change

-$292.5M

Total Shares Change

-183,127

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q4
Latest
Decreased
10M
-0.1%
$351.3M0.0%$35.18
0
2025-Q3
Decreased
10M
-1.6%
$262.8M0.0%$26.28
0
2025-Q2
Decreased
10.2M
-0.0%
$269.3M0.0%$26.50
0
2025-Q1
Decreased
10.2M
-0.1%
$245.5M0.0%$24.15
0
2024-Q4
Increased
10.2M
+0.1%
$409.3M0.0%$40.24
31
2024-Q3
First report
10.2M
-
$643.7M0.0%$63.31
0

Other major holders of VKTX: FMR LLC, BlackRock Finance, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used